Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.
2.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ā€ˇpossible cohort effect following the 2009 influenza pandemic.

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB.

Euro Surveill. 2019 Apr;24(15). doi: 10.2807/1560-7917.ES.2019.24.15.1900104.

3.

Effects of Absolute Humidity, Relative Humidity, Temperature, and Wind Speed on Influenza Activity in Toronto, Ontario, Canada.

Peci A, Winter AL, Li Y, Gnaneshan S, Liu J, Mubareka S, Gubbay JB.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02426-18. doi: 10.1128/AEM.02426-18. Print 2019 Mar 15.

4.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, Martineau C, Hickman R, Chan T, Jassem A, Petric M, Rose C, Bastien N, Li Y, Krajden M.

Clin Infect Dis. 2019 May 2;68(10):1754-1757. doi: 10.1093/cid/ciy876.

5.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

Chambers C, Skowronski DM, Rose C, Serres G, Winter AL, Dickinson JA, Jassem A, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Petric M, Krajden M.

Open Forum Infect Dis. 2018 Sep 4;5(9):ofy211. doi: 10.1093/ofid/ofy211. eCollection 2018 Sep.

6.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.

Skowronski DM, Chambers C, De Serres G, Dickinson JA, Winter AL, Hickman R, Chan T, Jassem AN, Drews SJ, Charest H, Gubbay JB, Bastien N, Li Y, Krajden M.

Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035. Erratum in: Euro Surveill. 2018 Jul;23(30):.

7.

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y.

J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.

8.

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y.

J Infect Dis. 2017 Sep 15;216(6):697-702. doi: 10.1093/infdis/jix393.

9.

Preface.

Di Girolamo N, Winter AL.

Vet Clin North Am Exot Anim Pract. 2017 Sep;20(3):xiii-xiv. doi: 10.1016/j.cvex.2017.06.001. No abstract available.

PMID:
28781047
10.

How to Report Exotic Animal Research.

Di Girolamo N, Winter AL.

Vet Clin North Am Exot Anim Pract. 2017 Sep;20(3):997-1010. doi: 10.1016/j.cvex.2017.04.010. Review.

PMID:
28781046
11.

Why Should We Direct Our Efforts Toward Evidence-Based Knowledge Creation?

Di Girolamo N, Winter AL.

Vet Clin North Am Exot Anim Pract. 2017 Sep;20(3):733-735. doi: 10.1016/j.cvex.2017.04.011. Review.

PMID:
28781030
12.

In veterinary trials reporting and communication regarding randomisation procedures is suboptimal.

Di Girolamo N, Giuffrida MA, Winter AL, Meursinge Reynders R.

Vet Rec. 2017 Aug 19;181(8):195. doi: 10.1136/vr.104035. Epub 2017 May 9.

PMID:
28487452
13.

Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.

Borgatti A, Winter AL, Stuebner K, Scott R, Ober CP, Anderson KL, Feeney DA, Vallera DA, Koopmeiners JS, Modiano JF, Froelich J.

PLoS One. 2017 Feb 21;12(2):e0172651. doi: 10.1371/journal.pone.0172651. eCollection 2017.

14.

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M.

Euro Surveill. 2017 Feb 9;22(6). pii: 30460. doi: 10.2807/1560-7917.ES.2017.22.6.30460.

15.

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.

Borgatti A, Koopmeiners JS, Sarver AL, Winter AL, Stuebner K, Todhunter D, Rizzardi AE, Henriksen JC, Schmechel S, Forster CL, Kim JH, Froelich J, Walz J, Henson MS, Breen M, Lindblad-Toh K, Oh F, Pilbeam K, Modiano JF, Vallera DA.

Mol Cancer Ther. 2017 May;16(5):956-965. doi: 10.1158/1535-7163.MCT-16-0637. Epub 2017 Feb 13.

16.

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ.

J Infect Dis. 2017 Apr 1;215(7):1059-1099. doi: 10.1093/infdis/jix074.

17.

Evaluation and Comparison of Multiple Test Methods, Including Real-time PCR, for Legionella Detection in Clinical Specimens.

Peci A, Winter AL, Gubbay JB.

Front Public Health. 2016 Aug 31;4:175. doi: 10.3389/fpubh.2016.00175. eCollection 2016.

18.

A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.

Fritz SE, Henson MS, Greengard E, Winter AL, Stuebner KM, Yoon U, Wilk VL, Borgatti A, Augustin LB, Modiano JF, Saltzman DA.

Vet Med Sci. 2016 Jun 6;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug.

19.

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Krajden M, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Kwindt TL, Bastien N, Li Y.

Clin Infect Dis. 2016 Jul 1;63(1):21-32. doi: 10.1093/cid/ciw176. Epub 2016 Mar 29.

20.

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.

Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Krajden M, Bastien N, Li Y.

Euro Surveill. 2016;21(11):30168. doi: 10.2807/1560-7917.ES.2016.21.11.30168.

21.

Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.

Skowronski DM, Sabaiduc S, Chambers C, Eshaghi A, Gubbay JB, Krajden M, Drews SJ, Martineau C, De Serres G, Dickinson JA, Winter AL, Bastien N, Li Y.

Euro Surveill. 2016;21(3):30112. doi: 10.2807/1560-7917.ES.2016.21.3.30112.

22.

2005-2015.

Winter AL.

J Am Vet Med Assoc. 2015 Oct 15;247(8):858-9. No abstract available.

PMID:
26693571
23.

1995-2005.

Winter AL.

J Am Vet Med Assoc. 2015 Oct 15;247(8):856-7. No abstract available.

PMID:
26693570
24.

Epidemiology of Enterovirus D68 in Ontario.

Peci A, Winter AL, Warshawsky B, Booth TF, Eshaghi A, Li A, Perusini S, Olsha R, Marchand-Austin A, Kristjanson E, Gubbay JB.

PLoS One. 2015 Nov 23;10(11):e0142841. doi: 10.1371/journal.pone.0142841. eCollection 2015.

25.

Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas.

German M, Olsha R, Kristjanson E, Marchand-Austin A, Peci A, Winter AL, Gubbay JB.

Emerg Infect Dis. 2015 Sep;21(9):1654-6. doi: 10.3201/eid2109.150472.

26.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Sep 11;33(38):4910-5. doi: 10.1016/j.vaccine.2015.07.044. Epub 2015 Jul 29.

27.
28.

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y.

J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17.

PMID:
25784728
29.

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Dickinson JA, Winter AL, Drews SJ, Fonseca K, Charest H, Gubbay JB, Petric M, Krajden M, Kwindt TL, Martineau C, Eshaghi A, Bastien N, Li Y.

Euro Surveill. 2015 Jan 29;20(4). pii: 21022. No abstract available.

30.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Jan 15;33(4):535-41. doi: 10.1016/j.vaccine.2014.11.044. Epub 2014 Dec 6.

31.

Performance of rapid influenza diagnostic testing in outbreak settings.

Peci A, Winter AL, King EC, Blair J, Gubbay JB.

J Clin Microbiol. 2014 Dec;52(12):4309-17. doi: 10.1128/JCM.02024-14. Epub 2014 Oct 15.

32.

Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.

Winter AL, Conklin HM, Tyc VL, Stancel H, Hinds PS, Hudson MM, Kahalley LS.

J Clin Exp Neuropsychol. 2014;36(8):818-30. doi: 10.1080/13803395.2014.943695. Epub 2014 Aug 15.

33.

Coxsackieviruses in ontario, january 2005 to december 2011.

Peci A, Winter AL, Eshaghi A, Marchand-Austin A, Olsha R, Lombardi N, Gubbay JB.

Int J Infect Dis. 2014 Aug;25:136-41. doi: 10.1016/j.ijid.2014.04.013. Epub 2014 Jun 2.

34.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

35.

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

Skowronski D, Chambers C, Sabaiduc S, De Serres G, Dickinson J, Winter A, Fonseca K, Gubbay J, Charest H, Petric M, Krajden M, Mahmud S, Van Caeseele P, Kwindt T, Eshaghi A, Bastien N, Li Y.

Euro Surveill. 2014 Feb 6;19(5). pii: 20690. Erratum in: Euro Surveill. 2014;19(6):20698.

36.

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.

Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.

J Infect Dis. 2014 Jul 1;210(1):126-37. Epub 2014 Jan 19.

PMID:
24446529
37.

Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.

Winter AL, Peci A, Eshaghi A, Baird M, Memari N, Kristjanson E, Balogun E, Higgins RR, Li A, Farrell DJ, Gubbay JB.

Infect Control Hosp Epidemiol. 2013 Nov;34(11):1225-8. doi: 10.1086/673455. Epub 2013 Sep 25.

PMID:
24113612
38.

Assessing the relative timeliness of Ontario's syndromic surveillance systems for early detection of the 2009 influenza H1N1 pandemic waves.

Chu A, Savage R, Whelan M, Rosella LC, Crowcroft NS, Willison D, Winter AL, Davies R, Gemmill I, Mucchal PK, Johnson I.

Can J Public Health. 2013 May 14;104(4):340-7.

PMID:
24044464
39.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.

Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Turner R, Rosella LC, Crowcroft NS.

Clin Infect Dis. 2013 Sep;57(6):820-7. doi: 10.1093/cid/cit404. Epub 2013 Jun 20.

40.

Variant influenza A (H1N1) virus infection in Canada.

Winter AL, Eshaghi A, Farrell DJ, King A, Li A, Li Y, Gubbay JB.

J Clin Virol. 2013 Jul;57(3):279-81. doi: 10.1016/j.jcv.2013.03.011. Epub 2013 Apr 15.

PMID:
23711507
41.

Contagious comments: what was the online buzz about the 2011 Quebec measles outbreak?

Pereira JA, Quach S, Dao HH, Kwong JC, Deeks SL, Crowcroft NS, Quan SD, Guay M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery, Evaluation Group.

PLoS One. 2013 May 15;8(5):e64072. doi: 10.1371/journal.pone.0064072. Print 2013.

42.

Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013.

Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter AL, Mahmud SM, Sabaiduc S, Gubbay JB, Charest H, Petric M, Fonseca K, Van Caeseele P, Kwindt TL, Krajden M, Eshaghi A, Li Y.

Euro Surveill. 2013 Jan 31;18(5). pii: 20394.

43.

Health care worker influenza immunization rates: the missing pieces of the puzzle.

Quach S, Pereira JA, Heidebrecht CL, Kwong JC, Guay M, Crowe L, Quan S, Bettinger JA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group.

Am J Infect Control. 2013 Aug;41(8):685-90. doi: 10.1016/j.ajic.2012.09.022. Epub 2013 Feb 5.

PMID:
23394884
44.

Incorporating scannable forms into immunization data collection processes: a mixed-methods study.

Heidebrecht CL, Quach S, Pereira JA, Quan SD, Kolbe F, Finkelstein M, Buckeridge DL, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group.

PLoS One. 2012;7(12):e49627. doi: 10.1371/journal.pone.0049627. Epub 2012 Dec 18.

45.

Barriers to the use of reminder/recall interventions for immunizations: a systematic review.

Pereira JA, Quach S, Heidebrecht CL, Quan SD, Kolbe F, Finkelstein M, Kwong JC; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group.

BMC Med Inform Decis Mak. 2012 Dec 17;12:145. doi: 10.1186/1472-6947-12-145. Review.

46.

Optimal number of samples to test for institutional respiratory infection outbreaks in Ontario.

Peci A, Marchand-Austin A, Winter AL, Gubbay JB.

Epidemiol Infect. 2013 Aug;141(8):1781-5. doi: 10.1017/S0950268812002531. Epub 2012 Nov 12. Erratum in: Epidemiol Infect. 2013 Aug;141(8):1786. Winter, A-J [corrected to Winter, A-L].

PMID:
23146341
47.

The use of syndromic surveillance for decision-making during the H1N1 pandemic: a qualitative study.

Chu A, Savage R, Willison D, Crowcroft NS, Rosella LC, Sider D, Garay J, Gemmill I, Winter AL, Davies RF, Johnson I.

BMC Public Health. 2012 Oct 30;12:929. doi: 10.1186/1471-2458-12-929.

48.

Community-acquired respiratory viruses and co-infection among patients of Ontario sentinel practices, April 2009 to February 2010.

Peci A, Winter AL, Gubbay JB, Skowronski DM, Balogun EI, De Lima C, Crowcroft NS, Rebbapragada A.

Influenza Other Respir Viruses. 2013 Jul;7(4):559-66. doi: 10.1111/j.1750-2659.2012.00418.x. Epub 2012 Aug 9.

49.

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.

Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, Crowcroft NS, Fradet MD, Bastien N, Li Y, Krajden M, Sabaiduc S, Petric M.

Clin Infect Dis. 2012 Aug;55(3):332-42. doi: 10.1093/cid/cis431. Epub 2012 Apr 26.

PMID:
22539661
50.

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.

Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter AL, Hottes TS, Fonseca K, Charest H, Drews SJ, Sabaiduc S, Bastien N, Li Y, Gardy JL, Petric M.

J Infect Dis. 2012 Jun 15;205(12):1858-68. doi: 10.1093/infdis/jis283. Epub 2012 Apr 9.

PMID:
22492921

Supplemental Content

Loading ...
Support Center